CCS1477-02: a phase 1/2a study of CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma
Trial… that have come back ( relapsed ) or has not responded ( refractory ) after previous treatment. The trial aims to find … side effects. Who can enter Adults with relapsed or refractory NHL which has been treated with one other … study of CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma …